Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function

This publication has 26 references indexed in Scilit:

• Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban
  The American Journal of Cardiology, 2003
• Preliminary experience with a high bolus dose of tirofiban during percutaneous coronary intervention
  Current Medical Research and Opinion, 2003
• Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban
  The American Journal of Cardiology, 2002
• Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention
  The American Journal of Cardiology, 2002
• Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions
  The American Journal of Cardiology, 2002
• Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization
  New England Journal of Medicine, 2001
• Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
  New England Journal of Medicine, 2001
• Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty
  Circulation, 1997
• Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
  Journal of the American Society of Echocardiography, 1989
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985